TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

This study has been completed.

Study NCT00110877 Information provided by Tibotec Pharmaceuticals, Ireland

First Received: May 13, 2005 Last Updated: November 25, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2011
Primary Completion Date:	January 2007 (Final data collection date for primary outcome measure)